Selected research
Industry Research
Posterior Pituitary Injection Industry Research Report 2026
Market perspective
The global Posterior Pituitary Injection market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Posterior Pituitary Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Posterior Pituitary Injection is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Posterior Pituitary Injection is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Posterior Pituitary Injection include Eisai (Liaoning) Pharmaceutical, Shanghai No. 1 Biochemical & Pharmaceutical, Shanghai Harvest Pharmaceutical, Nanjing Xinbai Pharmaceutical, Kamp Pharmaceutical, Chengdu Hepatunn Pharmaceutical, Beijing Science Sun and Anhui Hongye Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Posterior Pituitary Injection market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Posterior Pituitary Injection Market by Company
Eisai (Liaoning) Pharmaceutical
Shanghai No. 1 Biochemical & Pharmaceutical
Shanghai Harvest Pharmaceutical
Nanjing Xinbai Pharmaceutical
Kamp Pharmaceutical
Chengdu Hepatunn Pharmaceutical
Beijing Science Sun
Anhui Hongye Pharmaceutical
Posterior Pituitary Injection Segment by Type
Intramuscular Injection
Intravenous Drip
Posterior Pituitary Injection Segment by Application
Obstetric Oxytocia
Lung or Bronchi Bleeding
Gastrointestinal Bleeding
Others
Posterior Pituitary Injection Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Posterior Pituitary Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Posterior Pituitary Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Posterior Pituitary Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Posterior Pituitary Injection manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Posterior Pituitary Injection by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Posterior Pituitary Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Intramuscular Injection
- Intravenous Drip
Applications
- Obstetric Oxytocia
- Lung or Bronchi Bleeding
- Gastrointestinal Bleeding
- Others
Companies covered
- Eisai (Liaoning) Pharmaceutical
- Shanghai No. 1 Biochemical & Pharmaceutical
- Shanghai Harvest Pharmaceutical
- Nanjing Xinbai Pharmaceutical
- Kamp Pharmaceutical
- Chengdu Hepatunn Pharmaceutical
- Beijing Science Sun
- Anhui Hongye Pharmaceutical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Posterior Pituitary Injection Market Size (2021-2032)
- 2.2.2 Global Posterior Pituitary Injection Sales (2021-2032)
- 2.2.3 Global Posterior Pituitary Injection Market Average Price (2021-2032)
- 2.3 Posterior Pituitary Injection by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Intramuscular Injection
- 2.3.3 Intravenous Drip
- 2.4 Posterior Pituitary Injection by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Obstetric Oxytocia
- 2.4.3 Lung or Bronchi Bleeding
- 2.4.4 Gastrointestinal Bleeding
- 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Posterior Pituitary Injection Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Posterior Pituitary Injection Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Posterior Pituitary Injection Revenue of Manufacturers (2021-2026)
- 3.4 Global Posterior Pituitary Injection Average Price by Manufacturers (2021-2026)
- 3.5 Global Posterior Pituitary Injection Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Posterior Pituitary Injection, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Posterior Pituitary Injection, Product Type & Application
- 3.8 Global Manufacturers of Posterior Pituitary Injection, Established Date
- 3.9 Global Posterior Pituitary Injection Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Eisai (Liaoning) Pharmaceutical
- 4.1.1 Eisai (Liaoning) Pharmaceutical Company Information
- 4.1.2 Eisai (Liaoning) Pharmaceutical Business Overview
- 4.1.3 Eisai (Liaoning) Pharmaceutical Posterior Pituitary Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Eisai (Liaoning) Pharmaceutical Posterior Pituitary Injection Product Portfolio
- 4.1.5 Eisai (Liaoning) Pharmaceutical Recent Developments
- 4.2 Shanghai No. 1 Biochemical & Pharmaceutical
- 4.2.1 Shanghai No. 1 Biochemical & Pharmaceutical Company Information
- 4.2.2 Shanghai No. 1 Biochemical & Pharmaceutical Business Overview
- 4.2.3 Shanghai No. 1 Biochemical & Pharmaceutical Posterior Pituitary Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Shanghai No. 1 Biochemical & Pharmaceutical Posterior Pituitary Injection Product Portfolio
- 4.2.5 Shanghai No. 1 Biochemical & Pharmaceutical Recent Developments
- 4.3 Shanghai Harvest Pharmaceutical
- 4.3.1 Shanghai Harvest Pharmaceutical Company Information
- 4.3.2 Shanghai Harvest Pharmaceutical Business Overview
- 4.3.3 Shanghai Harvest Pharmaceutical Posterior Pituitary Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Shanghai Harvest Pharmaceutical Posterior Pituitary Injection Product Portfolio
- 4.3.5 Shanghai Harvest Pharmaceutical Recent Developments
- 4.4 Nanjing Xinbai Pharmaceutical
- 4.4.1 Nanjing Xinbai Pharmaceutical Company Information
- 4.4.2 Nanjing Xinbai Pharmaceutical Business Overview
- 4.4.3 Nanjing Xinbai Pharmaceutical Posterior Pituitary Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Nanjing Xinbai Pharmaceutical Posterior Pituitary Injection Product Portfolio
- 4.4.5 Nanjing Xinbai Pharmaceutical Recent Developments
- 4.5 Kamp Pharmaceutical
- 4.5.1 Kamp Pharmaceutical Company Information
- 4.5.2 Kamp Pharmaceutical Business Overview
- 4.5.3 Kamp Pharmaceutical Posterior Pituitary Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Kamp Pharmaceutical Posterior Pituitary Injection Product Portfolio
- 4.5.5 Kamp Pharmaceutical Recent Developments
- 4.6 Chengdu Hepatunn Pharmaceutical
- 4.6.1 Chengdu Hepatunn Pharmaceutical Company Information
- 4.6.2 Chengdu Hepatunn Pharmaceutical Business Overview
- 4.6.3 Chengdu Hepatunn Pharmaceutical Posterior Pituitary Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Chengdu Hepatunn Pharmaceutical Posterior Pituitary Injection Product Portfolio
- 4.6.5 Chengdu Hepatunn Pharmaceutical Recent Developments
- 4.7 Beijing Science Sun
- 4.7.1 Beijing Science Sun Company Information
- 4.7.2 Beijing Science Sun Business Overview
- 4.7.3 Beijing Science Sun Posterior Pituitary Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Beijing Science Sun Posterior Pituitary Injection Product Portfolio
- 4.7.5 Beijing Science Sun Recent Developments
- 4.8 Anhui Hongye Pharmaceutical
- 4.8.1 Anhui Hongye Pharmaceutical Company Information
- 4.8.2 Anhui Hongye Pharmaceutical Business Overview
- 4.8.3 Anhui Hongye Pharmaceutical Posterior Pituitary Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Anhui Hongye Pharmaceutical Posterior Pituitary Injection Product Portfolio
- 4.8.5 Anhui Hongye Pharmaceutical Recent Developments
5 Global Posterior Pituitary Injection Market Scenario by Region
- 5.1 Global Posterior Pituitary Injection Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Posterior Pituitary Injection Sales by Region: 2021-2032
- 5.2.1 Global Posterior Pituitary Injection Sales by Region: 2021-2026
- 5.2.2 Global Posterior Pituitary Injection Sales by Region: 2027-2032
- 5.3 Global Posterior Pituitary Injection Revenue by Region: 2021-2032
- 5.3.1 Global Posterior Pituitary Injection Revenue by Region: 2021-2026
- 5.3.2 Global Posterior Pituitary Injection Revenue by Region: 2027-2032
- 5.4 North America Posterior Pituitary Injection Market Facts & Figures by Country
- 5.4.1 North America Posterior Pituitary Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Posterior Pituitary Injection Sales by Country (2021-2032)
- 5.4.3 North America Posterior Pituitary Injection Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Posterior Pituitary Injection Market Facts & Figures by Country
- 5.5.1 Europe Posterior Pituitary Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Posterior Pituitary Injection Sales by Country (2021-2032)
- 5.5.3 Europe Posterior Pituitary Injection Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Posterior Pituitary Injection Market Facts & Figures by Country
- 5.6.1 Asia Pacific Posterior Pituitary Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Posterior Pituitary Injection Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Posterior Pituitary Injection Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Posterior Pituitary Injection Market Facts & Figures by Country
- 5.7.1 South America Posterior Pituitary Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Posterior Pituitary Injection Sales by Country (2021-2032)
- 5.7.3 South America Posterior Pituitary Injection Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Posterior Pituitary Injection Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Posterior Pituitary Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Posterior Pituitary Injection Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Posterior Pituitary Injection Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Posterior Pituitary Injection Sales by Type (2021-2032)
- 6.1.1 Global Posterior Pituitary Injection Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Posterior Pituitary Injection Sales Market Share by Type (2021-2032)
- 6.2 Global Posterior Pituitary Injection Revenue by Type (2021-2032)
- 6.2.1 Global Posterior Pituitary Injection Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Posterior Pituitary Injection Revenue Market Share by Type (2021-2032)
- 6.3 Global Posterior Pituitary Injection Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Posterior Pituitary Injection Sales by Application (2021-2032)
- 7.1.1 Global Posterior Pituitary Injection Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Posterior Pituitary Injection Sales Market Share by Application (2021-2032)
- 7.2 Global Posterior Pituitary Injection Revenue by Application (2021-2032)
- 7.2.1 Global Posterior Pituitary Injection Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Posterior Pituitary Injection Revenue Market Share by Application (2021-2032)
- 7.3 Global Posterior Pituitary Injection Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Posterior Pituitary Injection Value Chain Analysis
- 8.1.1 Posterior Pituitary Injection Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Posterior Pituitary Injection Production Mode & Process
- 8.2 Posterior Pituitary Injection Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Posterior Pituitary Injection Distributors
- 8.2.3 Posterior Pituitary Injection Customers
9 Global Posterior Pituitary Injection Analyzing Market Dynamics
- 9.1 Posterior Pituitary Injection Industry Trends
- 9.2 Posterior Pituitary Injection Industry Drivers
- 9.3 Posterior Pituitary Injection Industry Opportunities and Challenges
- 9.4 Posterior Pituitary Injection Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst